Molina Healthcare Posts Lower Q2 Earnings, Raises Full-Year Guidance; Stock Down
Molina Healthcare (MOH) reported Q2 2026 revenue of $10.87B, down 5% from Q2 2025, with GAAP net income falling to $60M ($1.19/share) from $255M ($4.75). Adjusted net income was $77M ($1.51). Medical care ratio rose to 92.2%. Despite weaker results, the company raised full-year guidance for GAAP earnings to at least $2.15/share and adjusted to at least $5.25/share.
How this was made
The 30-second read
Why it matters
Q2 results show weaker top line, higher medical costs (MCR up), and declining membership, but the company raised full-year EPS guidance, which can stabilize expectations even if revenue and margins remain pressured in the near term.
Market read
A guidance raise amid deteriorating Q2 operating metrics is likely to drive volatility, with traders focusing on whether the EPS floor is achievable through the 2026 Medicaid margin trough.
What to watch
The article flags Medicare Part D underperformance and new contract implementation as trough drivers; traders may want to separate one-time implementation effects from structural cost inflation given the MCR jump.
Background
Molina described 2026 as a trough year for Medicaid margins due to new contract implementation and Medicare Part D underperformance, while expecting profitable growth in 2027.
Ticker impact
Molina reported Q2 revenue and GAAP/adjusted earnings declines, but raised full-year GAAP and adjusted EPS guidance despite higher medical care ratio and fewer members.
Choppy trading likely, with downside risk if investors focus on rising MCR and shrinking membership, and upside support if the raised EPS guidance is viewed as credible for 2026 trough margins.
The article provides concrete Q2 deterioration (revenue, GAAP/adjusted earnings, MCR up to 92.2%, members down to 4.9M) while simultaneously lifting full-year GAAP EPS to at least $2.15 and adjusted EPS to at least $5.25, which can offset the operational concerns but may not fully neutralize the margin/membership narrative.
Market effects
Managed care insurers may see read-across on Medicaid margin trough expectations and the sensitivity of earnings to medical cost ratios and contract implementation.
Primarily US Medicaid and Medicare Part D exposure, relevant to domestic healthcare payer sentiment.
Limited direct global impact; mostly affects US healthcare payer risk appetite.
Counterpoint
The raised full-year GAAP and adjusted EPS guidance could indicate management has already worked through the trough-year margin headwinds, making the Q2 weakness more of a timing issue than a trend break.
Key entities
- companyMolina Healthcare, Inc.
Reported Q2 2026 results with revenue and earnings declines, higher MCR, fewer members, and raised full-year GAAP and adjusted EPS guidance.
